Learn More
Medchemexpress LLC GSK256066 Trifluoroacetate | 1415560-64-3 | 99.8% | C29H27F3N4O7S | 1 ML

Supplier: Medchemexpress LLC HY7006910MM/1ML
GSK256066 Trifluoroacetate is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. It is developed for the research of chronic obstructive pulmonary disease.
- Selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor
- IC50 of 3.2 pM for PDE4B
- Designed for inhaled administration
- Highly selective for PDE4
- Inhibits PDE4 isoforms A-D with equal affinity
- Inhibits tumor necrosis factor alpha production by lipopolysaccharide (LPS)-stimulated human peripheral blood monocytes
- Inhibits eosinophil number in bronchoalveolar lavage in animal models
- Inhibits LPS-induced pulmonary neutrophilia
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.